Mineral vaccine adjuvants for use in oncology
Mineral adjuvants for vaccination in oncology
Article REF: N4965 V1
Mineral vaccine adjuvants for use in oncology
Mineral adjuvants for vaccination in oncology

Author : Patrick FRAYSSINET

Publication date: April 10, 2014 | Lire en français

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

3. Mineral vaccine adjuvants for use in oncology

3.1 Aluminized compounds

Aluminum compounds including aluminum phosphate (AlPO 4 ), aluminum hydroxide [Al(OH) 3 ] and alum-precipitated vaccines (potassium aluminum sulfate salt: KAl(SO 4 ) 2 · 12H 2 O) remain the most commonly used adjuvants for human and veterinary vaccines. These adjuvants are formed by co-precipitation with the antigen, or brought into the presence of the antigen after adjuvant synthesis. They are relatively difficult to characterize, and their characteristics can vary.

An example of an aluminum salt-based adjuvant...

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Ongoing reading
Mineral vaccine adjuvants for use in oncology

Article included in this offer

"Healthcare technologies"

( 124 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details
Contact us